Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and Hypertension
about
Correction: Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and Hypertension.Losartan, but not Enalapril and Valsartan, Inhibits the Expression of IFN-γ, IL-6, IL-17F and IL-22 in PBMCs from Rheumatoid Arthritis PatientsEffects of captopril and valsartan on ventricular remodeling and inflammatory cytokines after interventional therapy for AMILower serum levels of Meteorin-like/Subfatin in patients with coronary artery disease and type 2 diabetes mellitus are negatively associated with insulin resistance and inflammatory cytokines
P2860
Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and Hypertension
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Atorvastatin, Losartan and Cap ...... rtery Disease and Hypertension
@ast
Atorvastatin, Losartan and Cap ...... rtery Disease and Hypertension
@en
type
label
Atorvastatin, Losartan and Cap ...... rtery Disease and Hypertension
@ast
Atorvastatin, Losartan and Cap ...... rtery Disease and Hypertension
@en
prefLabel
Atorvastatin, Losartan and Cap ...... rtery Disease and Hypertension
@ast
Atorvastatin, Losartan and Cap ...... rtery Disease and Hypertension
@en
P2093
P2860
P50
P1433
P1476
Atorvastatin, Losartan and Cap ...... rtery Disease and Hypertension
@en
P2093
Ali Akbar Nasiri
Farhad Kohan
Mahmood Sheikh Fathollahi
Mohammad Masoumi
Nazanin Ebrahimi
Zahra Sepehri
Zohre Kiani
P2860
P304
P356
10.1371/JOURNAL.PONE.0168312
P407
P577
2016-12-29T00:00:00Z